- Home
- Publications
- Publication Search
- Publication Details
Title
HER-2/neu as a target for cancer vaccines
Authors
Keywords
-
Journal
Immunotherapy
Volume 2, Issue 2, Pages 213-226
Publisher
Future Medicine Ltd
Online
2010-03-06
DOI
10.2217/imt.09.89
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties
- (2014) A. D. Gritzapis et al. JOURNAL OF IMMUNOLOGY
- Cancer immunotherapy
- (2009) Constantin N. Baxevanis et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
- (2009) Robert Kreitman CURRENT PHARMACEUTICAL DESIGN
- Denileukin diftitox: a novel immunotoxin
- (2009) George Manoukian et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
- (2009) Mary L. Disis et al. JOURNAL OF CLINICAL ONCOLOGY
- Longterm Followup Assessment of a HER2/neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients
- (2009) Jeremy D. Gates et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Use of tumour-responsive T cells as cancer treatment
- (2009) Mary L Disis et al. LANCET
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
- (2008) Asna Amin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The E75 HER2/neu peptide vaccine
- (2008) Elizabeth A. Mittendorf et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting the Stroma by T Cells to Limit Tumor Growth
- (2008) B. Zhang CANCER RESEARCH
- Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
- (2008) G. E. Peoples et al. CLINICAL CANCER RESEARCH
- Therapeutic Vaccination Halts Disease Progression in BALB-neuT Mice: The Amplitude of Elicited Immune Response Is Predictive of Vaccine Efficacy
- (2008) Barbara Cipriani et al. HUMAN GENE THERAPY
- Protective Immunity Against neu-Positive Carcinomas Elicited by Electroporation of Plasmids Encoding Decreasing Fragments of Rat Neu Extracellular Domain
- (2008) Simona Rolla et al. HUMAN GENE THERAPY
- Tumor immunology top 10 list
- (2008) Olivera J. Finn IMMUNOLOGICAL REVIEWS
- Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neuPeptide (AE37) Vaccine
- (2008) Jarrod P. Holmes et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started